Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
With
Gyrus ACMI, Inc.
The purpose of this study is to demonstrate that the Bipolar TURP using the Vista Controlled Tissue Resection System is safe and efficacious as a surgical treatment for men with symptomatic BPH, allowing a reduction in the post-operative hospitalization. It is expected that bipolar TURP will be safe and efficacious for the surgical treatment of BPH and will allow a \< 24 hour post-operative hospital stay in \> 50% of patients undergoing this procedure.
Age
50–85
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Symptomatic benign prostatic hyperplasia including patients with acute urinary retention;
Peak urinary flow rate \< 12 ml/sec;
American Urological Association (AUA) symptom score \> 12.
You may not be if
Previous open or transurethral prostatic surgery;
History of urethral stricture;
Failure to discontinue alpha-adrenergic blocking agents for at least 14 days prior to surgery;
Failure to discontinue 5-alpha reductase inhibitor for at least 1 month prior to surgery;
Patient interested in future fertility;
Patient with known neurogenic bladder dysfunction;
Untreated urinary tract infection;
American Society of Anesthesiologist (ASA) Class \>III;
Patients requiring anticoagulation with Coumadin or Heparin;
Patient unable or unwilling to comply with follow-up schedule.
